Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-21

Clinical Trial Update: Primaquine Enantiomers in G6PD Deficient Human Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating primaquine enantiomers in G6PD-deficient human volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Primaquine Enantiomers (primaquine)

Snippet

Sponsor: University of Mississippi, Oxford | Conditions: G6PD Deficiency | Phase 1 | Status: COMPLETED